APOL1 and Mortality in Patients on Dialysis

Cardiorenal Med. 2019;9(4):261-264. doi: 10.1159/000501303. Epub 2019 Jun 11.

Authors

Mariana Murea¹, Lijun Ma¹, Barry I Freedman²

Affiliations

¹ Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
² Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA, bfreedma@wakehealth.edu.

PMID: 31185465
DOI: 10.1159/000501303

No abstract available

Keywords: APOL1; African Americans; Cardiovascular disease; Chronic kidney disease; Survival.

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Apolipoprotein L1
Apolipoproteins
Black or African American*
Humans
Kidney Failure, Chronic*
Renal Dialysis

Substances

APOL1 protein, human
Apolipoprotein L1
Apolipoproteins

Grants and funding

R01 DK070941/DK/NIDDK NIH HHS/United States